A possible asymmetry at the checkpoint

A recently published systematic review and meta-analysis indicated that anti-PD-1 treatment may confer superior survival outcomes as compared to anti-PD-L1. We propose mechanistic explanations supporting this finding.

Detalles Bibliográficos
Autor principal: Milano, Gerard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2020
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330153/
https://www.ncbi.nlm.nih.gov/pubmed/32619818
http://dx.doi.org/10.1016/j.tranon.2020.100821

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330153/
https://www.ncbi.nlm.nih.gov/pubmed/32619818
http://dx.doi.org/10.1016/j.tranon.2020.100821

Ejemplares similares